Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 3 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Jan 13, 2026
Last action: Jun 23, 2026 — Reported out of Assembly Committee, 2nd Reading
Session: 222
Momentum: 55 · Moderate

PASSAGE PROBABILITY

5.2% Unlikely

Why this number

Stage base Floor Consideration — base rate 18%, measured from NJ's completed sessions
Momentum +1 55/100 from the pace of recorded action
Time since last action -14 109 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.